These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37738403)

  • 1. PhenoDriver: interpretable framework for studying personalized phenotype-associated driver genes in breast cancer.
    Li Y; Zhang SW; Xie MY; Zhang T
    Brief Bioinform; 2023 Sep; 24(5):. PubMed ID: 37738403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel network control model for identifying personalized driver genes in cancer.
    Guo WF; Zhang SW; Zeng T; Li Y; Gao J; Chen L
    PLoS Comput Biol; 2019 Nov; 15(11):e1007520. PubMed ID: 31765387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network controllability-based algorithm to target personalized driver genes for discovering combinatorial drugs of individual patients.
    Guo WF; Zhang SW; Feng YH; Liang J; Zeng T; Chen L
    Nucleic Acids Res; 2021 Apr; 49(7):e37. PubMed ID: 33434272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring gene-patient association to identify personalized cancer driver genes by linear neighborhood propagation.
    Huang Y; Chen F; Sun H; Zhong C
    BMC Bioinformatics; 2024 Jan; 25(1):34. PubMed ID: 38254011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A workflow to study mechanistic indicators for driver gene prediction with Moonlight.
    Nourbakhsh M; Saksager A; Tom N; Chen XS; Colaprico A; Olsen C; Tiberti M; Papaleo E
    Brief Bioinform; 2023 Sep; 24(5):. PubMed ID: 37551622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Method for Identifying the Potential Cancer Driver Genes Based on Molecular Data Integration.
    Zhang W; Wang SL
    Biochem Genet; 2020 Feb; 58(1):16-39. PubMed ID: 31115714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.
    Lu X; Li X; Liu P; Qian X; Miao Q; Peng S
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29364829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpreting pathways to discover cancer driver genes with Moonlight.
    Colaprico A; Olsen C; Bailey MH; Odom GJ; Terkelsen T; Silva TC; Olsen AV; Cantini L; Zinovyev A; Barillot E; Noushmehr H; Bertoli G; Castiglioni I; Cava C; Bontempi G; Chen XS; Papaleo E
    Nat Commun; 2020 Jan; 11(1):69. PubMed ID: 31900418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-Omic Data Improve Prediction of Personalized Tumor Suppressors and Oncogenes.
    Sudhakar M; Rengaswamy R; Raman K
    Front Genet; 2022; 13():854190. PubMed ID: 35620468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-cancer onco-signatures reveal a novel mitochondrial subtype of luminal breast cancer with specific regulators.
    Simeone I; Ceccarelli M
    J Transl Med; 2023 Jan; 21(1):55. PubMed ID: 36717859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. InDEP: an interpretable machine learning approach to predict cancer driver genes from multi-omics data.
    Yang H; Liu Y; Yang Y; Li D; Wang Z
    Brief Bioinform; 2023 Sep; 24(5):. PubMed ID: 37649392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A network-based method for identifying cancer driver genes based on node control centrality.
    Li F; Li H; Shang J; Liu JX; Dai L; Liu X; Li Y
    Exp Biol Med (Maywood); 2023 Feb; 248(3):232-241. PubMed ID: 36573462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncovering driver genes in breast cancer through an innovative machine learning mutational analysis method.
    Taheri G; Habibi M
    Comput Biol Med; 2024 Mar; 171():108234. PubMed ID: 38430742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of driver genes with tumor suppressive and oncogenic roles in gastric cancer.
    Wang T; Liu Y; Zhao M
    PeerJ; 2017; 5():e3585. PubMed ID: 28729958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A computational method for clinically relevant cancer stratification and driver mutation module discovery using personal genomics profiles.
    Wang L; Li F; Sheng J; Wong ST
    BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S6. PubMed ID: 26099165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mutational landscape of a US Midwestern breast cancer cohort reveals subtype-specific cancer drivers and prognostic markers.
    Vellichirammal NN; Tan YD; Xiao P; Eudy J; Shats O; Kelly D; Desler M; Cowan K; Guda C
    Hum Genomics; 2023 Jul; 17(1):64. PubMed ID: 37454130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DEOD: uncovering dominant effects of cancer-driver genes based on a partial covariance selection method.
    Amgalan B; Lee H
    Bioinformatics; 2015 Aug; 31(15):2452-60. PubMed ID: 25819079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying cancer type specific oncogenes and tumor suppressors using limited size data.
    Pavel AB; Vasile CI
    J Bioinform Comput Biol; 2016 Dec; 14(6):1650031. PubMed ID: 27712196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CBNA: A control theory based method for identifying coding and non-coding cancer drivers.
    Pham VVH; Liu L; Bracken CP; Goodall GJ; Long Q; Li J; Le TD
    PLoS Comput Biol; 2019 Dec; 15(12):e1007538. PubMed ID: 31790386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DRdriver: identifying drug resistance driver genes using individual-specific gene regulatory network.
    Huang YE; Zhou S; Liu H; Zhou X; Yuan M; Hou F; Chen S; Chen J; Wang L; Jiang W
    Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36869849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.